TNFSF10 and cancer: Since tumor cells are more susceptible to TRAIL-induced cell death compared to healthy cells, and TRAIL can selectively target tumor-associated feeder cells, TRAIL has been the center of cancer therapy studies (22, 24, 45–48, 164).